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Hans Clevers
Hubrecht Institute
Growing up, I believed that academics
were shielded from the clutter of everyday
life and had the peace to think, discuss,
perform the occasional experiment and
think somemore. After starting a research
lab, however, I discovered there was not
much peace in academia. The day was
just not long enough to fit everything in,
and though a sabbatical leave always
lurked at the horizon, there never seemed
to be a good moment to take a break.
After three hectic years at the helm of
the Royal Netherlands Academy and a
particularly productive period for the lab
(in my virtual absence, as the postdocs
like to point out), a sabbatical could no
longer be postponed. With two sons at
university, I did not need to stay in one
place for an entire year. My years at the
Academy made me aware of how pro-
foundly individual scientists and their sci-
ence are affected by their environment, so
my sabbatical became a world tour: six
weeks each in six countries, interspersed
by four week stints back in Utrecht, with
great university cities serving as a home
base from which to travel to teach and
talk science. From Melbourne, I visited
Sidney, Adelaide, and Brisbane, and
from the Weizmann, I went to Tel Aviv,
Haifa, and Jerusalem. New York is next,
then San Diego and Paris, and finally
Hong Kong. The experience will be a
unique opportunity to see what drives sci-
entists today, where science is going, and
what the local and global challenges are.788 Cell 163, November 5, 2015 ª2015 ElsevMy ‘‘Big Year’’
Stuart Firestein
Columbia University
Four years ago, an exceptional under-
grad in my lab asked me for a letter of
reference for a Masters program in the
History and Philosophy of Science (HPS)
at Cambridge University. When I read
about the program, my first thought was,
‘‘Hell, I’d like to do this.’’ At the time, I
was just finishing a book about how our
ignorance fuels science. Three years later,
having completed my sentence.er, term
as department Chair, I contacted HPS
and asked to join their Masters program
during my sabbatical. They felt I might
be ‘‘a bit too senior’’ for that, but sug-
gested instead that I come as a Visiting
Scholar, an offer I couldn’t refuse.
Many scientists may consider philoso-
phers and historians of science to be like
birdwatchers, impacting scientists about
as much as ornithologists affect birds.
That may be true for benchwork, but a
key part of our job is shaping the process
and trajectory of science. Our perspective
on thesematters so crucial to the success
of science is generally limited to our own
meager individual experience. At HPS, I
was exposed to the rigorous scholarship
and broad view of science historians. I
learned, among other things, how turn-
of-the-century physics imbedded itself
into the philosophical and social thinking
of the culture. Might biologists today be
missing a similar opportunity to engage
citizens? At an age when one would think
my most affecting experiences were
behind me, I had the most important
year of my life at HPS.ier Inc.Embracing the Whiteboard
Leonie Ringrose
Humboldt University of Berlin
Last winter, I found myself in the un-
usual position of having some time on
my hands. My Junior PI position at IMBA
Vienna had come to an end, and I was still
negotiating my senior position at Hum-
boldt University in Berlin. Ever since a
brief fling with kinetic mathematical
modeling during my Ph.D. in the 1990s,
I’ve been wanting to bring the crisp
formalism of mathematical modeling to
the perplexing questions of epigenetics
but never seemed to find the time to
pursue this. So when I met Martin Ho-
ward, a physicist at the John Innes Centre
in Norwich who uses stochastic modeling
to study epigenetic memory in plants, I
was inspired by his approach and
managed to talk him into hosting me for
a few months to see if we could adapt
his models to questions in Drosophila
epigenetics.
Once there, I found it wonderfully
refreshing to have the sole task of working
on my project. I overcame my initial
fear of giving group meetings with no
PowerPoint slides, just a whiteboard.
The project was a success: the combina-
tion of Martin’s expertise and interest in
the topic, the environment of theoretical
thinkers, combined with my background
in the details of the biology, turned out
to be very fruitful. I thoroughly benefitted
not just from taking a career break but
also from leaving my comfort zone and
taking a leap into the unknown. And I
will certainly be making more use of
modeling, and of the whiteboard, in the
future.
Rescuing Abandoned Drugs
Rene Bernards
Netherlands Cancer Institute
After studying cancer genetics for 23
years, I wanted to get a closer look at
howpharma approaches cancer drug dis-
covery. To do this, I spent a 9 month
sabbatical at the Discovery Oncology
Department at Genentech in San Fran-
cisco. My first surprise was that the
research atmosphere there is rather aca-
demic, with small research groups led by
accomplished scientists. They were very
generous and quickly made me feel at
home. I was especially interested to learn
how decisions are made about which
molecules are taken forward in clinical
development. This led to the second sur-
prise, namely that, in pharma, it is practi-
cally a mantra that drugs must have
demonstrated single agent activity before
drug combinations are considered. Due
to the extensive redundancy and feed-
back loops in the major signaling path-
ways in cancer, many good drugs may
be abandoned early on for lack of such
single agent activity. As one example,
had the highly successful melanoma
drug vemurafenib (a BRAF inhibitor) first
been tested in BRAF mutant colon can-
cer, the drug would have failed miserably,
as it only shows activity in this context in
combination with EGFR inhibition.
So the take-home lesson from my sab-
batical is that some perfectly good drugs
may have been needlessly abandoned
and might be resurrected from their
graves with synthetic lethal screens to
find effective drug combinations. It was
time well spent, and I came away with
lots of new ideas to work on!TB for Two
K. Heran Darwin and Russell E. Vance
NewYork UniversityMedical Center and University
of California, Berkeley (HHMI)
We are two biologists, from opposite
sides of the country and distinct training
backgrounds, but united in our interest
in infectious diseases. Heran’s lab fo-
cuses on the genetics of Mycobacterium
tuberculosis pathogenesis, whereas Rus-
sell’s lab focuses on innate immune re-
sponses to infection. M. tuberculosis
infects more than 2 billion people world-
wide, causing over a million deaths annu-
ally. There is no effective vaccine, and the
bacterium is highly contagious, requiring
special BSL3 procedures to be safely
studied in the lab. On top of this, tubercu-
losis (TB) is a complex disease where
both the pathogen and the host are
complicit in causing mortality.
Because TB and immunology are both
fields that are difficult for outsiders to
enter, we realized that we would both
benefit from a ‘‘mutual’’ sabbatical. After
discussions starting back in 2012, and
the intervening chaos of Superstorm
Sandy that disrupted Heran’s lab at
NYU, we were finally able to arrange for
Heran to visit Berkeley for a sabbatical
to coincide with Russell’s ‘‘stay-batical’’
this fall/spring. To help facilitate interac-
tion, we are sharing a single office at Ber-
keley. Our immediate goals are for Russell
to get in the lab and learn how to work
with TB, and for Heran to think more
about TB from the perspective of the
host. Our longer-term ambitions are to
try to bring together our knowledge of
microbiology and immunology to make
progress on this difficult and globally
challenging disease.Cell 163, November 5, 2015 ª2015 Elsevier Inc. 789
